Effects of estriol on growth, gene expression and estrogen response element activation in human breast cancer cell lines

Maturitas

Volumn 77, Issue 4, 2014, Pages 336-343

  Diller, Magnus ^a   Schüler, Susanne ^a   Buchholz, Stefan ^a   Lattrich, Claus ^a   Treeck, Oliver ^a   Ortmann, Olaf ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Breast cancer; Estradiol; Estriol; Growth

Indexed keywords

CYCLIN A2; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; ESTRADIOL; ESTRIOL; ESTROGEN RECEPTOR ALPHA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KI 67 ANTIGEN; MYC PROTEIN; PROGESTERONE RECEPTOR; PROTEIN MYB; ESTROGEN RECEPTOR ALPHA, HUMAN; MYC PROTEIN, HUMAN; PROTEIN C MYB; RNA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SAFETY; ESTROGEN ACTIVITY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; ESTROGEN RESPONSIVE ELEMENT; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOGENICITY; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BREAST TUMOR; CHEMISTRY; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN A2; CYCLIN B1; ESTRIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; PROTO-ONCOGENE PROTEINS C-MYB; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PROGESTERONE; RESPONSE ELEMENTS; RNA;

EID: 84896397867     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.01.004     Document Type: Article

References (44)

1. C. Crandall, L. Petersen, P.A. Ganz, and G.A. Greendale Association of breast cancer and its therapy with menopause-related symptoms Menopause 11 2004 519 530
2. J. Bines, D.M. Oleske, and M.A. Cobleigh Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer J Clin Oncol 14 1996 1718 1729
3. J. Bernhard, D. Zahrieh, and J.J. Zhang et al. Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer Br J Cancer 98 2008 25 33
4. D. Cella, and L.J. Fallowfield Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy Breast Cancer Res Treat 107 2008 167 180
5. B. Ettinger, H. Hait, K.Z. Reape, and H. Shu Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach Menopause 15 2008 885 889
6. R. Ponzone, N. Biglia, M.E. Jacomuzzi, F. Maggiorotto, L. Mariani, and P. Sismondi Vaginal oestrogen therapy after breast cancer: is it safe? Eur J Cancer 41 2005 2673 2681
7. A. Kendall, and M. Dowsett Novel concepts for the chemoprevention of breast cancer through aromatase inhibition Endocr Relat Cancer 13 2006 827 837
8. M. Hickey, C. Saunders, A. Partridge, N. Santoro, H. Joffe, and V. Stearns Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer Ann Oncol 19 2008 1669 1680
9. M. Moegele, S. Buchholz, S. Seitz, and O. Ortmann Vaginal estrogen therapy in postmenopausal breast cancer patients treated with aromatase inhibitors Arch Gynecol Obstet 285 2012 1397 1402
10. L.A. Mattsson, and G. Cullberg Vaginal absorption of two estriol preparations. A comparative study in postmenopausal women Acta Obstet Gynecol Scand 62 1983 393 396
11. K.J. Buhling, U. Eydeler, S. Borregaard, R. Schlegelmilch, and M. Suesskind Systemic bioavailability of estriol following single and repeated vaginal administration of 0.03 mg estriol containing pessaries Arzneimittelforschung 62 2012 378 383
12. G. Pfeiler, C. Glatz, and R. Königsberg et al. Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients Climacteric 14 2011 339 344
13. P. Cole, and B. MacMahon Oestrogen fractions during early reproductive life in the aetiology of breast cancer Lancet 1 1969 604 606
14. H.M. Lemon Estriol prevention of mammary carcinoma induced by 7,12-dimethylbenzanthracene and procarbazine Cancer Res 35 1975 1341 1353
15. H.H. Wotiz, S.C. Chattoraj, M. Kudisch, and R.E. Müller Impeding estrogens and the etiology of breast cancer Cancer Res 38 1978 4012 4020
16. H.M. Lemon, P.F. Kumar, C. Peterson, J.F. Rodriguez-Sierra, and K.M. Abbo Inhibition of radiogenic mammary carcinoma in rats by estriol or tamoxifen Cancer 63 1989 1685 1692
17. S. Jozan, B. Kreitmann, and F. Bayard Different effects of oestradiol, oestriol, oestetrol and of oestrone on human breast cancer cells (MCF-7) in long term tissue culture Acta Endocrinol 98 1981 73 80
18. B.S. Katzenellenbogen Biology and receptor interactions of estriol and estriol derivatives in vitro and in vivo J Steroid Biochem 20 1984 1033 1037
19. M. Gupta, A. McDougal, and S. Safe Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells J Steroid Biochem Mol Biol 67 1998 413 419
20. H. Pang, and L.E. Faber Estrogen and rapamycin effects on cell cycle progression in T47D breast cancer cells Breast Cancer Res Treat 70 2001 21 26
21. S.C. Brooks, E.R. Locke, and H.D. Soule Estrogen receptor in a human cell line (MCF-7) from breast carcinoma J Biol Chem 248 1973 6251 6253
22. D. Chalbos, F. Vignon, I. Keydar, and H. Rochefort Estrogens stimulate cell growth and induce secretory proteins in a human breast cancer cell line (T47D) J Clin Endocrinol Metab 55 1982 276 283
23. V.S. Wilson, K. Bobseine, and L.E. Gray Jr. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists Toxicol Sci 81 2004 69 77
24. A. Ståhlberg, P. Aman, B. Ridell, P. Mostad, and M. Kubista Quantitative real-time PCR method for detection of B-lymphocyte monoclonality by comparison of kappa and lambda immunoglobulin light chain expression Clin Chem 49 2003 51 59
25. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
26. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
27. H. Kaneko, T. Fujikawa, and K.S. Alam et al. Cooperative and differential effects of estrogen, prolactin, 22K and 20K human growth hormones on cyclin D1/PRAD1 gene expression in T-47D human breast cancer cells Biochem Mol Biol Int 46 1998 411 414
28. S. Mandal, and J.R. Davie Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells J Cell Physiol 224 2010 28 32
29. M. Lippman, M.E. Monaco, and G. Bolan Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture Cancer Res 37 1977 1901 1907
30. D.S. Bermudez, L.E. Gray, and V.S. Wilson Modelling defined mixtures of environmental oestrogens found in domestic animal and sewage treatment effluents using an in vitro oestrogen-mediated transcriptional activation assay (T47D-KBluc) Int J Androl 35 2012 397 406
31. K.B. Horwitz, Y. Koseki, and W.L. McGuire Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen Endocrinology 103 1978 1742 1751
32. J.R. Pasqualini, C. Gelly, and F. Lecerf Biological effects and morphological responses to estriol, estriol-3-sulfate, estriol-17-sulfate and tamoxifen in a tamoxifen-resistant cell line (R-27) derived from MCF-7 human breast cancer cells Eur J Cancer Clin Oncol 22 1986 1495 1501
33. J.R. Schultz, L.N. Petz, and A.M. Nardulli Estrogen receptor alpha and Sp1 regulate progesterone receptor gene expression Mol Cell Endocrinol 201 2003 165 175
34. A. Fazzari, M.G. Catalano, and A. Comba et al. The control of progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone-binding globulin (SHBG) Mol Cell Endocrinol 172 2001 31 36
35. A.L. Gartel, and K. Shchors Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes Exp Cell Res 283 2003 17 21
36. S.F. Doisneau-Sixou, C.M. Sergio, J.S. Carroll, R. Hui, E.A. Musgrove, and R.L. Sutherland Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells Endocr Relat Cancer 10 2003 179 186
37. D. Dubik, T.C. Dembinski, and R.P. Shiu Stimulation of c-myc oncogene expression associated with estrogen-induced growth of human breast cancer cells Cancer Res 47 1987 6517 6521
38. J.A. Vendrell, F. Magnino, and E. Danis et al. Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell growth and cell transformation J Mol Endocrinol 32 2004 397 414
39. C.H. Yam, T.K. Fung, and R.Y.C. Poon Cyclin A in cell cycle control and cancer Cell Mol Life Sci 59 2002 1317 1326
40. A.R. Thorner, K.A. Hoadley, J.S. Parker, S. Winkel, R.C. Millikan, and C.M. Perou In vitro and in vivo analysis of B-Myb in basal-like breast cancer Oncogene 28 2009 742 751
41. R. Yerushalmi, R. Woods, P.M. Ravdin, M.M. Hayes, and K.A. Gelmon Ki67 in breast cancer: prognostic and predictive potential Lancet Oncol 11 2010 174 183
42. K. Rotti, J. Stevens, D. Watson, and C. Longcope Estriol concentrations in plasma of normal, non-pregnant women Steroids 25 1975 807 816
43. M. van Haaften, G.H. Donker, A.A. Haspels, and J.H. Thijssen Oestrogen concentrations in plasma, endometrium, myometrium and vagina of postmenopausal women, and effects of vaginal oestriol (E3) and oestradiol (E2) applications J Steroid Biochem Mol Biol 33 1989 647 653
44. P. Neven, G. Donders, and M. Mögele et al. Ultra low dose vaginal estriol and Lactobacillus acidophilus (Gynoflor) in early breast cancer survivors on aromatase inhibitors: pharmacokinetic, efficacy and safety results from a phase I trial Cancer Res 72 Suppl. 24 2012 [Abstract nr P2-12-06]